Former FDA leader Hahn lands at CDMO Nucleus

Nucleus Radiopharma Inc. named former FDA Commissioner Stephen Hahn as its new CEO, days after his departure from Flagship Pioneering-backed Harbinger Health Inc. came to light. Hahn joins the CDMO after four years at Harbinger; he was at FDA in 2019-21, following stints at the University of Texas MD Anderson Cancer Center and the University of Pennsylvania’s Perelman School of Medicine.

Anne White is retiring as EVP and president of Lilly Neuroscience, effective at year-end. White has been with Eli Lilly and Co. (NYSE:LLY) for 30 years...